CIK 0000873303
- Large accelerated filer
Sarepta Therapeutics, Inc.
Sign in to watch- Ticker
- SRPT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 930797222
- Phone
- +1 617-274-4000
- Business address
- 215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,613 shares (to pay taxes)
- 4 Gift Chief Financial Officer gave 250 shares (gift)
- 4 Open-market sale Director sold 10,500 shares at $124.84 ($1,310,820)
- 4 Open-market sale Director sold 1,636 shares at $125.55 ($205,400)
- 4 Grant or award EVP, General Counsel acquired 2,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Head of R&D, CSO gave up 4,558 shares (to pay taxes)
- 4 Grant or award Director acquired 2,842 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Gift Director gave 746 shares (gift)
- 4 Open-market sale Chief Financial Officer sold 5,985 shares at $137.36 ($822,100)
- 4 Open-market buy Director bought 37,038 shares at an average $133.80 ($4,955,728)
- 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
- 4 Planned sale EVP, General Counsel sold 38,957 shares at an average $161.61 ($6,296,029)
- 4 Shares withheld for taxes Head of R&D, CSO gave up 2,182 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Customer Officer gave up 2,352 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,483 shares (to pay taxes)
- 4 Planned sale Chief Tech Ops Officer sold 11,757 shares at an average $163.13 ($1,917,891)
Page 5 of 34 · 672 filings